Inventiva (IVA) Liabilities and Shareholders Equity (2018 - 2025)

Inventiva (IVA) recorded quarterly Liabilities and Shareholders Equity of $290.4 million in Q4 2025, down 99.86% quarter-over-quarter from $202.6 billion in Q2 2025, and up 128.46% on a YoY basis from $127.1 million in Q4 2024.

Inventiva (IVA) Liabilities and Shareholders Equity (2018 - 2025) Analysis & Trends

Inventiva's Liabilities and Shareholders Equity history runs 8 years deep, the most recent figure standing at $290.4 million for Q4 2025.

  • In Q4 2025, Liabilities and Shareholders Equity rose 128.46% year-over-year to $290.4 million; the TTM figure through Dec 2025 stood at $203.0 billion (up 78694.75% YoY), while the FY2025 annual figure was $290.4 million, up 128.46% from the prior year.
  • Liabilities and Shareholders Equity was $290.4 million for Q4 2025 at Inventiva, down from $202.6 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $202.6 billion in Q2 2025 to a low of $115662.5 in Q2 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $18.5 billion across 5 years, with a median of $127.1 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity plunged 99.92% in 2022, then surged 977941.76% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $139.5 million in 2021, then slipped by 15.19% to $118.4 million in 2022, then plunged by 36.76% to $74.8 million in 2023, then soared by 69.86% to $127.1 million in 2024, then jumped by 128.46% to $290.4 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $290.4 million (Q4 2025), $202.6 billion (Q2 2025), and $127.1 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 37.37 Mn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 14.93 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 1.73 Bn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 33.89 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 23.64 Mn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 26.48 Bn
9 Abivax 95.45 Bn 95.45 Bn - 640.56 Mn
10 Inventiva 8.93 Mn -259.80 Mn - 290.44 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 290.44 Mn
Jun 30, 2025 202.57 Bn
Dec 31, 2024 127.13 Mn
Jun 30, 2024 20.71 Mn
Dec 31, 2023 74.84 Mn
Oct 11, 2023 34.96 Mn
Dec 31, 2022 118.35 Mn
Jun 30, 2022 115,662.54
Dec 31, 2021 139.55 Mn
Jun 30, 2021 141.16 Mn
Mar 31, 2021 159.49 Mn
Dec 31, 2020 165.63 Mn
Jun 30, 2020 75.70 Mn
Dec 31, 2019 63.05 Mn
Dec 31, 2018 91.10 Mn